Healthcare -
Biotechnology - NASDAQ - US
$ 8.01
-0.497 %
$ 1.26 B
Market Cap
-6.21
P/E
OCUL - TOTAL EQUITY
Total Equity OCUL - Ocular Therapeutix, Inc.
91.1 M
LAST VALUE
1.76%
2 YEAR CAGR
20.50%
5 YEAR CAGR
13.45%
10 YEAR CAGR